1. Home
  2. FTFT vs CANF Comparison

FTFT vs CANF Comparison

Compare FTFT & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

HOLD

Current Price

$1.07

Market Cap

6.9M

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.09

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTFT
CANF
Founded
N/A
1994
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.2M
IPO Year
2008
2011

Fundamental Metrics

Financial Performance
Metric
FTFT
CANF
Price
$1.07
$3.09
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$50.00
AVG Volume (30 Days)
45.8K
32.5K
Earning Date
05-19-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,829,805.00
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
N/A
N/A
Revenue Growth
77.46
N/A
52 Week Low
$0.56
$0.17
52 Week High
$4.03
$10.40

Technical Indicators

Market Signals
Indicator
FTFT
CANF
Relative Strength Index (RSI) 38.69 42.31
Support Level $1.00 $2.89
Resistance Level $1.32 $3.24
Average True Range (ATR) 0.08 0.16
MACD -0.01 -0.04
Stochastic Oscillator 3.86 9.09

Price Performance

Historical Comparison
FTFT
CANF

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the production and sale of fruit juice concentrates (including fruit purees and fruit juices), fruit beverages (including fruit juice beverages and fruit cider beverages) in the PRC. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The Company classified its business segments into Trading Commission and Consulting services, Fast-Moving Consumer Goods (FMCG), and Supply Chain Financing and Trading.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: